Global Next Generation Sequencing (NGS) Market Growth (Status and Outlook) 2024-2030

Global Next Generation Sequencing (NGS) Market Growth (Status and Outlook) 2024-2030

According to our LPI (LP Information) latest study, the global Next Generation Sequencing (NGS) market size was valued at US$ 3609.9 million in 2023. With growing demand in downstream market, the Next Generation Sequencing (NGS) is forecast to a readjusted size of US$ 4601.3 million by 2030 with a CAGR of 3.5% during review period.

The research report highlights the growth potential of the global Next Generation Sequencing (NGS) market. Next Generation Sequencing (NGS) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Next Generation Sequencing (NGS). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Next Generation Sequencing (NGS) market.

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

Key Features:

The report on Next Generation Sequencing (NGS) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Next Generation Sequencing (NGS) market. It may include historical data, market segmentation by Type (e.g., Targeted Sequencing, Whole Exome Sequencing), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Next Generation Sequencing (NGS) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Next Generation Sequencing (NGS) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Next Generation Sequencing (NGS) industry. This include advancements in Next Generation Sequencing (NGS) technology, Next Generation Sequencing (NGS) new entrants, Next Generation Sequencing (NGS) new investment, and other innovations that are shaping the future of Next Generation Sequencing (NGS).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Next Generation Sequencing (NGS) market. It includes factors influencing customer ' purchasing decisions, preferences for Next Generation Sequencing (NGS) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Next Generation Sequencing (NGS) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Next Generation Sequencing (NGS) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Next Generation Sequencing (NGS) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Next Generation Sequencing (NGS) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Next Generation Sequencing (NGS) market.

Market Segmentation:

Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Segmentation by application
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen

Please note: The report will take approximately 2 business days to prepare and deliver.